These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 16839321

  • 1. Psychosocial outcomes and drug attributes affecting treatment choice in men receiving sildenafil citrate and tadalafil for the treatment of erectile dysfunction: results of a multicenter, randomized, open-label, crossover study.
    Dean J, Hackett GI, Gentile V, Pirozzi-Farina F, Rosen RC, Zhao Y, Warner MR, Beardsworth A.
    J Sex Med; 2006 Jul; 3(4):650-661. PubMed ID: 16839321
    [Abstract] [Full Text] [Related]

  • 2. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I, Montorsi F, Jackson G, Mirone V, Chan ML, Loughney K, Vail GM, Beardsworth A.
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [Abstract] [Full Text] [Related]

  • 3. An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy.
    Eardley I, Mirone V, Montorsi F, Ralph D, Kell P, Warner MR, Zhao Y, Beardsworth A.
    BJU Int; 2005 Dec; 96(9):1323-32. PubMed ID: 16287454
    [Abstract] [Full Text] [Related]

  • 4. A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction.
    Rubio-Aurioles E, Porst H, Kim ED, Montorsi F, Hackett G, Morales AM, Stuckey B, Būttner H, West TM, Huynh NN, Lenero E, Burns P, Kopernicky V.
    J Sex Med; 2012 May; 9(5):1418-29. PubMed ID: 22429760
    [Abstract] [Full Text] [Related]

  • 5. Sensitivity of the psychological and interpersonal relationship scales to oral therapies for erectile dysfunction.
    Rosen R, Broderick G, Shabsigh R, Swindle R, Lockhart D, Cameron A.
    J Sex Med; 2005 Jul; 2(4):461-8. PubMed ID: 16422840
    [Abstract] [Full Text] [Related]

  • 6. Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction.
    Buvat J, Büttner H, Hatzimouratidis K, Vendeira PA, Moncada I, Boehmer M, Henneges C, Boess FG.
    J Sex Med; 2013 Jun; 10(6):1592-602. PubMed ID: 23551622
    [Abstract] [Full Text] [Related]

  • 7. A randomized clinical trial investigating treatment choice in Chinese men receiving sildenafil citrate and tadalafil for treating erectile dysfunction.
    Bai WJ, Li HJ, Jin JJ, Xu WP, Sebastian S, Wang XF.
    Asian J Androl; 2017 Jun; 19(4):500-504. PubMed ID: 27101805
    [Abstract] [Full Text] [Related]

  • 8. Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors.
    Tolrà JR, Campaña JMC, Ciutat LF, Miranda EF.
    J Sex Med; 2006 Sep; 3(5):901-909. PubMed ID: 16942534
    [Abstract] [Full Text] [Related]

  • 9. Treatment preferences in men with erectile dysfunction: an open label study in Korean men switching from sildenafil citrate to tadalafil.
    Ahn TY, Lee SW, Kim SW, Yang DY, Park NC, Min KS, Park K, Paick JS, Dyachkova Y, Dwight T, Lee MS.
    Asian J Androl; 2007 Nov; 9(6):760-70. PubMed ID: 17968461
    [Abstract] [Full Text] [Related]

  • 10. Timing of dose relative to sexual intercourse attempt in previous sildenafil citrate users treated with tadalafil.
    Glina S, Sotomayor M, Gatchalian E, Yaman O, Dyachkova Y, Markey C, Kopernicky V.
    J Sex Med; 2006 Mar; 3(2):309-19. PubMed ID: 16490025
    [Abstract] [Full Text] [Related]

  • 11. Psychosocial outcomes after initial treatment of erectile dysfunction with tadalafil once daily, tadalafil on demand or sildenafil citrate on demand: results from a randomized, open-label study.
    Hatzimouratidis K, Buvat J, Büttner H, Vendeira PA, Moncada I, Boehmer M, Henneges C, Boess FG.
    Int J Impot Res; 2014 Mar; 26(6):223-9. PubMed ID: 24784894
    [Abstract] [Full Text] [Related]

  • 12. Sildenafil citrate improves self-esteem, confidence, and relationships in men with erectile dysfunction: Results from an international, multi-center, double-blind, placebo-controlled trial.
    Althof SE, O'leary MP, Cappelleri JC, Hvidsten K, Stecher VJ, Glina S, King R, Siegel RL, International SEAR Study Group.
    J Sex Med; 2006 May; 3(3):521-9. PubMed ID: 16681478
    [Abstract] [Full Text] [Related]

  • 13. Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: results of a European multicenter, open-label study of patient preference.
    Ströberg P, Murphy A, Costigan T.
    Clin Ther; 2003 Nov; 25(11):2724-37. PubMed ID: 14693300
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST.
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.
    Broderick GA, Donatucci CF, Hatzichristou D, Torres LO, Valiquette L, Zhao Y, Loughney K, Sides GD, Ahuja S.
    J Sex Med; 2006 Jul; 3(4):668-675. PubMed ID: 16839323
    [Abstract] [Full Text] [Related]

  • 16. Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States.
    Sharlip ID, Shumaker BP, Hakim LS, Goldfischer E, Natanegara F, Wong DG.
    J Sex Med; 2008 Mar; 5(3):716-25. PubMed ID: 18304286
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.